In the article titled “Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke” [1], additional references should have been cited, included in the text below as references 61-68 [2–9].
The details of where these references should have each been cited are as follows:
Reference 61. In Page 2, at the end of first paragraph, after the sentence “In addition, assessing endothelial damage is important when evaluating EPC levels [5].”
References 62, 63. In Page 6, at the last paragraph of the first column, after the sentence “This occurs in patients with acute coronary syndrome and acute ischemic stroke, with a peak in EPC counts and vascular endothelial growth factor(VEGF) levels occurring on the seventh day after the ischemic event [16, 38–40].”
Reference 64. In Page 6, at the first paragraph of the second column, after the sentence “In previous studies involving patients with myocardial infarction, a higher number of EPCs were associated with better prognosis, increased myocardial salvage, and more collateral in the ischemic zone [41, 42].”
References 65-68. In Page 7, at the sixth line of the second column, after “Indeed, Mandraffino et al. [60].”
References
- 1.Gołąb-Janowska M., Paczkowska E., Machaliński B., et al. Effects of angiotensin-converting enzyme inhibition on circulating endothelial progenitor cells in patients with acute ischemic stroke. Stem Cells International. 2018;2018:10. doi: 10.1155/2018/2827580.2827580 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Fadini G. P., Agostini C., Sartore S., Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis. 2007;194(1):46–54. doi: 10.1016/j.atherosclerosis.2007.03.046. [DOI] [PubMed] [Google Scholar]
- 3.Taguchi A., Matsuyama T., Moriwaki H., et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation. 2004;109(24):2972–2975. doi: 10.1161/01.CIR.0000133311.25587.DE. [DOI] [PubMed] [Google Scholar]
- 4.Rouhl R. P., Damoiseaux R. J., van Oostenbrugge J., Tervaert J. W., Lodder J. Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke. 2008;39(7):2158–2165. doi: 10.1161/STROKEAHA.107.507251. [DOI] [PubMed] [Google Scholar]
- 5.Numaguchi Y., Sone T., Okumura K., et al. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation. 2006;114(1 Suppl):I114–I119. doi: 10.1161/CIRCULATIONAHA.105.000588. [DOI] [PubMed] [Google Scholar]
- 6.Mandraffino G., Sardo M. A., Riggio S., et al. Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. Hypertension Research. 2011;34(7):876–883. doi: 10.1038/hr.2011.56. [DOI] [PubMed] [Google Scholar]
- 7.Gullo A. L., Mandraffino G., Sardo M. A., et al. Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. Scandinavian Journal of Rheumatology. 2013;43:184–193. doi: 10.3109/03009742.2013.836564. [DOI] [PubMed] [Google Scholar]
- 8.Lo Gullo A., Mandraffino G., Bagnato G., et al. Vitamin D status in rheumatoid arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number. PLoS One. 2015;10(8, article e0134602) doi: 10.1371/journal.pone.0134602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mandraffino G., Aragona C. O., Basile G., et al. CD34+ cell count predicts long lasting life in the oldest old. Mechanisms of Ageing and Development. 2017;164:139–145. doi: 10.1016/j.mad.2017.03.003. [DOI] [PubMed] [Google Scholar]